Bruker Corp (FRA:BKD)
€ 54.16 0.16 (0.3%) Market Cap: 8.54 Bil Enterprise Value: 10.52 Bil PE Ratio: 25.45 PB Ratio: 5.19 GF Score: 89/100

Bruker Corp at Jefferies London Healthcare Conference (Virtual) Transcript

Nov 16, 2021 / 12:20PM GMT
Release Date Price: €72 (-1.37%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

Thanks, everybody, for joining us. Man, it feels great to be back in person at the Jefferies London Conference. I'm Brandon Couillard. I cover the life science tools and diagnostics sector here at the firm. Very happy to have Bruker with us back at the conference in person this year. And joining us for this conversation, CFO, Gerald Herman. Thanks for being here.

Gerald N. Herman
Bruker Corporation - Executive VP & CFO

Hello, everyone. Yes, pleasure to be here. Thanks for all of you for being here.

Questions & Answers

Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

Maybe just to start off the conversation, I think it would be helpful just to sort of level set the year, which has been pretty impressive in terms of you've been putting up successive series of big beats and raises. If we look at where you're kind of expecting organic growth for the year, you're talking kind of 17% at the midpoint, which is double

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot